Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Adeno-associated viral vector expressing lipoprotein lipase

EU orphan designation number: EU/3/04/194   
Active ingredient: Adeno-associated viral vector expressing lipoprotein lipase
Indication: Treatment of lipoprotein lipase deficiency
Sponsor: uniQure biopharma B.V.
Meibergdreef 61, NL-1105 BA Amsterdam, Nederland
EU Centralised marketing authorisation: A centralised EU marketing authorisation has been obtained under the name Glybera on 25/10/2012 with the number EU/1/12/791

   Public summary of scientific opinion     EPAR

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
10/03/2004 Centralised Orphan - Designation EMEA/OD/079/03 (2004)804 of 08/03/2004
20/12/2006 Centralised Orphan - Transfer of orphan designation EMEA/OD/079/03/T/01 (2006)7024 of 18/12/2006
27/08/2010 Corrigendum (2010)5972 of 25/08/2010
17/07/2012 Other procedure EMEA/OD/079/03